secwatch.observer — SEC 8-K summary
======================================

Issuer:     Transcode Therapeutics, Inc. (RNAZ)
CIK:        0001829635
Form:       8-K
Filed at:   2025-04-21T23:59:59+00:00
Accession:  0001104659-25-036866
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TransCode adjourns special meeting due to lack of quorum; reconvenes May 2 for reverse split vote
--------------------------------------------------------------------------------

- Only 12.73% of outstanding shares voted at April 21 special meeting; quorum required one-third.
- Adjourned meeting reconvenes May 2, 2025 at 9:30 a.m. ET virtually at www.virtualshareholdermeeting.com/RNAZ2025SM2.
- Proposal 1: reverse stock split at ratio from 1:10 to 1:40, board discretion.
- Proposal 2: adjournment if needed; record date still April 2, 2025.
- New vote deadline May 1, 2025 at 11:59 p.m. ET; company continues solicitation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1829635/000110465925036866/0001104659-25-036866-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1829635/000110465925036866/tm2512771d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-036866

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer